Solve-Funded Phase 2 Observational Study Yields More Support for Repurposing Rapamycin to Reduce a Broad Range of ME/CFS Symptoms
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a nonprofit organization that conducts research and observational studies on ME/CFS to find treatments for people with […]
Repurposing Rapamycin: A Report On the First Biomarker-Driven Treatment Trial for ME/CFS
In 2025, Simmaron Research was the second recipient of Solve’s ME/CFS Catalyst Award in support of its study, “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection-Associated Chronic Conditions.” The […]
Simmaron’s Solve ME/CFS Catalyst Award-Winning Rapamycin Trial Yields Promising Treatment Findings
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a non-profit organization dedicated to understanding ME/CFS and related diseases and to treating people with these diseases. […]